AZN: Summary for ASTRAZENECA PLC ADS - Yahoo! Canada Finance

Day's Range:	44.83 - 45.42
52wk Range:	29.96 - 47.61
Volume:	2,232,790
Avg Vol (3m):	1,528,170
Market Cap:	65.61B
P/E (ttm):	11.94
EPS (ttm):	3.79
Div & Yield:	2.09 (4.60%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add AZN to Portfolio

Download Data

HEADLINES

•	Novartis opens new flu vaccine plant in US
	at Reuters (Tue 3:09pm)

•	Sage Advice On Vytorin
	at Forbes.com (Mon, Nov 23)

•	CORRECTED - Next-generation flu vaccine plant to open in U.S.
	at Reuters (Mon, Nov 23)

•	Good News for Bristol-Myers
	Zacks.com (Mon, Nov 23)

•	Worse Than You Think
	at Forbes.com (Fri, Nov 20)

•	U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
	PRNewswire (Fri, Nov 20)

•	FDA OKs Abilify for autism-linked irritability
	AP (Fri, Nov 20)

•	Big Pharma Mergers: Good News Or Bad?
	Investor's Business Daily (Fri, Nov 20)

•	Swine flu may have hit one peak; more to come
	at Reuters (Fri, Nov 20)

•	This Baby Is a Nice Addition
	at Motley Fool (Fri, Nov 20)

•	UPDATE - Swine flu may be peaking in US, reports indicate
	at Reuters (Fri, Nov 20)

More Headlines for AZN...

ANALYST

EPS Est (next year) (Dec-07) :	4.06
EPS Est (in 2 years) (Dec-08) :	4.24
Avg Rec (current)*:	3.1
PEG Ratio:	1.60

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

AstraZeneca plc (AZN)